Global Digital COPD Management Market Strategic Research Report

Scope of the Report

The global Digital COPD Management market size is predicted to grow from US$ 629 million in 2025 to US$ 989 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Digital COPD Management refers to a digital health service system that utilizes artificial intelligence (AI), big data, mobile health applications, wearable devices, telemedicine, and smart pulmonary function monitoring equipment to provide long-term, continuous, and personalized management for patients with Chronic Obstructive Pulmonary Disease (COPD). By collecting data such as pulmonary function metrics, blood oxygen saturation, respiratory rate, activity levels, symptom changes, medication adherence, and acute exacerbation events—and integrating this with AI algorithms—the system enables disease risk prediction, symptom monitoring, rehabilitation guidance, medication management, and remote physician follow-ups. Digital COPD management helps patients improve treatment adherence, reduce the risk of acute exacerbations, enhance quality of life, and alleviate pressure on healthcare resources. Its primary applications include stable-phase COPD management, early warning of acute exacerbations, pulmonary rehabilitation training, home oxygen therapy management, and remote chronic disease management; it represents a key direction in the digital management of respiratory diseases.

Driven by the rising global prevalence of COPD, an aging population, increasing demand for chronic respiratory disease management, the growth of telemedicine, and the widespread adoption of smart medical devices, the industry is shifting from traditional hospital-based follow-up models toward home-based, continuous, and intelligent management. Recent opportunities are concentrated in areas such as AI-driven acute exacerbation prediction, home pulmonary function monitoring, smart inhaled medication management, remote pulmonary rehabilitation, wearable blood oxygen monitoring, digital therapeutics, and hospital-based chronic disease management platforms. Core industry competitiveness lies in AI algorithms for respiratory diseases, capabilities in pulmonary function data analysis and multi-device data integration, patient behavior management, medical service coordination, and clinical validation. Current industry pain points include insufficient long-term patient adherence, difficulty in timely detection of symptom fluctuations, inconsistent quality of home monitoring data, a lack of device interoperability standards, limited management capacity in primary care, and the need to refine business models for digital health services. Solutions involve deploying smart spirometers, blood oxygen monitors, and mobile health apps; predicting exacerbation risks via AI models; and establishing long-term management systems that combine remote physician oversight, medication reminders, exercise-based rehabilitation, and health education. Overall, Digital COPD Management is evolving into a comprehensive chronic disease management model characterized by "continuous monitoring, intelligent early warning, remote intervention, and pulmonary rehabilitation management."

This report presents a comprehensive overview of the global Digital COPD Management market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Symptom Monitoring
• Lung Function Management
• Acute Exacerbation Prediction
• Medication Adherence Management
• Others

Segment by FEV1

• FEV1 ≥80%
• FEV1 50%–79%
• FEV1 30%–49%
• FEV1＜30%

Segment by Application

• Hospital Respiratory Department Management
• Home Health Self-Management
• Insurance-Based Health Management
• Telemedicine

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Digital COPD Management market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital Respiratory Department Management, Home Health Self-Management, Insurance-Based Health Management evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact